🌍 On #WorldTheranosticsDay, learn more about this pioneering cancer treatment and meet the IHI projects boosting theranostics development and manufacture in Europe...
☢️ #Theranostics refers to the practice of pairing a diagnostic test and therapy that both bind to the same target.
👉 IHI has 3 theranostics projects that are working to boost the development and manufacture of theranostics as a targeted treatment for hard-to-treat cancers.
More: https://link.europa.eu/kK9dgf
#health #research #cancer

Great to have been at the Theranostics World Congress with the Accelerate.EU consortium.

We were happy to share the progress made on Astatine-211 and targeted alpha therapies.

#AccelerateEU #Astatine211 #Theranostics #TargetedAlphaTherapy #NuclearMedicine #IHI

#Theranostics is a revolutionary way of treating cancers, by combining one component that detects the cancer & another that attacks it. Find out how our projects are improving treatments & building the EU's theranostics ecosystem
👉 https://lnkd.in/eTT67MmJ

#BeatingCancerPlan #CancerResearch #HorizonEU

Nanoparticles That Hunt Plaque and Heal Arteries? It’s Happening.

Imagine a tiny tool—thousands of times smaller than a human hair—that can find and shrink dangerous plaque in your arteries without traditional drugs. That’s exactly what researchers in Australia and Canada have developed with a new class of “theranostic” nanoparticles.

Called Por-NPs, these microscopic particles target the immune cells in artery walls that absorb cholesterol. When overwhelmed, these cells become foam cells and contribute to artery-clogging plaques—a major cause of heart attacks and strokes. The nanoparticles not only detect these trouble spots using fluorescence or PET scans, but they also reduce inflammation and help these immune cells unload cholesterol, disrupting the cycle that drives heart disease.

In tests on mice prone to atherosclerosis and fed a high-fat diet, the results were striking: plaque size shrank by up to 52%, and inflammation dropped dramatically. Most of the nanoparticles then traveled safely to the liver—where they deposited the excess cholesterol for natural processing.

This dual-action approach is still experimental but holds promise as a powerful new way to see and treat cardiovascular disease at the same time—possibly even before symptoms appear.

The research was published in the journal Materials Today Bio.

Heart health & disease focus
#HeartHealth #Cardiovascular #Atherosclerosis #HeartDisease #StrokePrevention

Nanotech & biomedical innovation
#Nanomedicine #Nanoparticles #Theranostics #MedicalNanotech #AdvancedMaterials

Research & science
#MedicalBreakthrough #Biotech #TranslationalMedicine #FutureOfMedicine #CuttingEdgeScience

Regional / discovery angle (optional)
#AustraliaResearch #CanadaResearch #GlobalHealthInnovation

Nanoparticles That Hunt Plaque and Heal Arteries? It’s Happening.

Imagine a tiny tool—thousands of times smaller than a human hair—that can find and shrink dangerous plaque in your arteries without traditional drugs. That’s exactly what researchers in Australia and Canada have developed with a new class of “theranostic” nanoparticles.

Called Por-NPs, these microscopic particles target the immune cells in artery walls that absorb cholesterol. When overwhelmed, these cells become foam cells and contribute to artery-clogging plaques—a major cause of heart attacks and strokes. The nanoparticles not only detect these trouble spots using fluorescence or PET scans, but they also reduce inflammation and help these immune cells unload cholesterol, disrupting the cycle that drives heart disease.

In tests on mice prone to atherosclerosis and fed a high-fat diet, the results were striking: plaque size shrank by up to 52%, and inflammation dropped dramatically. Most of the nanoparticles then traveled safely to the liver—where they deposited the excess cholesterol for natural processing.

This dual-action approach is still experimental but holds promise as a powerful new way to see and treat cardiovascular disease at the same time—possibly even before symptoms appear.

The research was published in the journal Materials Today Bio.

Cardiovascular & Heart Health
#HeartHealth #CardiovascularHealth #Atherosclerosis #HeartDisease #StrokePrevention #PlaqueReduction #HealthyArteries #CirculatorySystem

Nanotechnology & Nanomedicine
#Nanoparticles #Nanomedicine #Nanotechnology #NanoTherapy #NanoHealth #MedicalNanotech #Theranostics #NanoInnovation

Research & Medical Breakthrough
#MedicalBreakthrough #MedicalInnovation #ScienceNews #BiomedicalResearch #FutureOfMedicine #NextGenMedicine #LifeSciences #HealthTech

Inflammation & Immunology
#AntiInflammatory #Immunotherapy #CholesterolControl #InflammationResearch #ImmuneHealth

This year's #ChemSciSymposium is fast approaching!

This year's symposium is bringing together the wider Chemical Science community to explore the chemistry of imaging, biosensing and diagnostics, and to celebrate 15 years of the Royal Society of Chemistry's flagship journal.

Register and find out more: invt.io/1lxb70hkb1o

Want to know more about the type of research being presented?

Check out the themed collection that highlights recent studies and research from the speakers: rsc.li/46RuHAy

#Chemistry #Conference #Sensors #Diagnostics #Theranostics

Happy proofs day to those who celebrate…

Details forthcoming!

#radiopharmaceuticals #theranostics #hcc

Looking forward to speaking AASLD Liver Meeting in San Diego at the Advanced Diagnostics and Monitoring for Hepatocellular Carcinoma.

Please join us this Monday Nov 18 from 230-330p in Ballroom 6E!

#livercancer #TLM24 #theranostics #radiopharmaceuticals

🏥 Our new Accelerate.EU project aims to boost #cancer care in Europe by advancing the development and manufacture of #theranostics, where a #diagnostic test and #therapy that both bind to the same target are paired up.
💡 Find out more: https://europa.eu/!96WpwV
#IHITransformingHealth #HorizonEU #MissionCancer
ACCELERATE.EU to pioneer novel approach to tackling hard-to-treat cancers

The new project aims to boost cancer care in Europe by advancing the development and manufacture of therapies and diagnostics based on the radioactive isotope astatine-211.

IHI Innovative Health Initiative

🔥Super proud PI moment!🔥

Our all-star postbac, Divya Nambiar, was selected to give an oral presentation for the Alavi-Bradley Symposium on Molecular Imaging and #theranostics!

Others in her session had doctorates.

She's applying to MD/PhD programs now!